Press Release
September 9, 2022
Effective August 31, 2022, Ontario will move away from COVID-19-specific guidances in favor of an “all-virus approach,” meaning new isolation guidelines will apply for other illnesses, such as the flu, as well.
The guidelines for the general public are as follows:
This approach is an attempt to decrease the risks of all respiratory illnesses. Other provinces across Canada have already moved to this step in respiratory illness prevention.
The Paxlovid antiviral medication for COVID-19 will be available to community members who are at higher risk for serious illness from COVID-19 infection. Paxlovid must be taken within five (5) days of symptoms. If you are COVID-19 positive and wish to obtain the Paxlovid antiviral medication, or need medications for symptom relief, please call the Akwesasne Medical Clinic at 613-575-2341 ext. 3214 or 3215 to review your eligibility.
If you have any questions regarding the new COVID-19 guidance, please contact the Community Health Program at 613-575-2341 ext. 3220.
IHT5